DarioHealth appoints Steven Nelson as CCO; President Richard Anderson departs

DarioHealth Corp.

Steven Nelson, formerly CEO of Contigo Health (Premier Inc.), named Chief Commercial Officer effective June 5, 2024.
Nelson receives $400,000 base salary, annual bonus up to $400,000 tied to GAAP revenue targets (targets redacted).
Nelson granted time-vesting option for 500,000 shares and performance options for up to 400,000 (2024) and 450,000 shares (2025-2027) vested on revenue milestones.
President Richard Anderson mutually agreed to step down; no disagreement; will stay as consultant and Advisory Board member.
Anderson's departure not related to any disagreement with company's operations, policies, or practices.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Anderson

President

DRIO · DarioHealth Corp.

Effective: 2024-05-30
Filed: June 5, 2024, 7:59 PM ET

the Company and Richard Anderson, the Company’s President, mutually agreed for Mr. Anderson to cease serving in his role as President of the Company.

Appointed

Steven Nelson

Chief Commercial Officer

DRIO · DarioHealth Corp.

Effective: 2024-06-05
Filed: June 5, 2024, 7:59 PM ET

appointed Steven Nelson, age 51, to serve as its Chief Commercial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Anderson departed as President at DarioHealth Corp..

Action: ceased serving
Role: President

Exact text from the filing

the Company and Richard Anderson, the Company’s President, mutually agreed for Mr. Anderson to cease serving in his role as President of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Nelson was appointed as Chief Commercial Officer at DarioHealth Corp..

Action: appointed
Role: Chief Commercial Officer

Exact text from the filing

appointed Steven Nelson, age 51, to serve as its Chief Commercial Officer.

View on SEC.gov

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-24-068526

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.